Smoking cessation

NICE proposes adding cytisine to stop-smoking guideline

The NICE consultation on cytisinicline follows NHS England's announcement that varenicline would be available again for NHS patients as a generic.…

Vapes to be used in community pharmacy smoking cessation pilot

A Kent-based community pharmacy smoking cessation pilot has been launched “in response to the government's ambition for England to be smoke-free by 2030”.…

Smoking cessation drug to be provided on NHS three years after its withdrawal over carcinogen concerns

NHS England says generic varenicline could help more than 85,000 people stop smoking each year.…

Varenicline planned for return but ‘not before’ end of 2024, says manufacturer

Pfizer has said smoking cessation therapy varenicline will be reintroduced to the UK, after being withdrawn in October 2021.…

Revisiting 2023: a look back at the year in pharmacy

In this episode, The PJ team take a look back at 2023 in pharmacy before sharing their predictions for the year ahead.…

Smoking cessation medicine cytisine to be available in January 2024, distributor confirms

Exclusive: Cytisine was approved for use in the UK by the Medicines and Healthcare products Regulatory Agency in March 2019, but no supplies have been previously available.…

Scottish government considers nicotine addiction treatment for children aged under 12 years

Experts say that teachers and parents are raising concerns about nicotine addiction in children aged under 12 years.…

E-cigarettes associated with greatest chance of smoking cessation, suggests Cochrane review

The review revealed that 10–19% of people were likely to quit smoking using an e-cigarette, 12–16% using varenicline and 10–18% using cytisine.…

Filling the gap in smoking cessation therapies: a race to a smoke-free 2030

Nicotine replacement therapy is currently the only pharmacological treatment available in the UK to help tobacco smokers quit, but this is set to change.…

Patients to be referred to community pharmacy smoking cessation scheme from lung cancer checks

The expansion will allow patients to be referred to the smoking cessation scheme from targeted lung health checks, which are offered to current and ex-smokers aged 55–74 years.…